Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
The American Journal of Gastroenterology|November 16, 2018
Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-UpJeffrey M Lackner, James Jaccard, Christopher D Radziwon, et al.
The Journal of Dermatological Treatment|May 16, 2019
The clinical efficacy of treatment using the autologous non-cultured epidermal cell suspension technique for stable vitiligo in 41 patientsBin Liu, Hui-Heng Chen, Zhong-Hai Liu, et al.
Gastroenterology|April 28, 2018
Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel SyndromeJeffrey M Lackner, James Jaccard, Laurie Keefer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2013
Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndromeJeffrey M Lackner, Chang-Xing Ma, Laurie Keefer, et al.
Toxicology and Applied Pharmacology|August 28, 2021
Curcumin ameliorates hypertension via gut-brain communication in spontaneously hypertensive ratHong-Bao Li, Meng-Lu Xu, Meng-Meng Du, et al.
The Journal of Infection|March 6, 2007
Toll-like receptor 4 siRNA attenuates LPS-induced secretion of inflammatory cytokines and chemokines by macrophagesZhe Xu, Chang-Xing Huang, Yu Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 15, 2021
Resveratrol (RV): A pharmacological review and call for further researchLi-Xue Zhang, Chang-Xing Li, Mohib Ullah Kakar, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2023
Biological Evaluation of the Antibacterial Retinoid CD437 in Cutibacterium acnes InfectionXiao-Wen Huang, Wen Pan, Mei-Zhen Zhong, et al.
Pageof 22